Technology | December 13, 2013

Philips Unveils First Digital Detector PET/CT System at RSNA 2013

philips vereos pet/ct systems rsna 2013 molecular nuclear imaging
philips vereos pet/ct systems rsna 2013 molecular nuclear imaging

December 13, 2013 — Philips unveiled the Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.

 

Based on Philips’ proprietary digital photon counting technology, the Vereos PET/CT is the first PET/CT system in the industry to use digital silicon photomultiplier detectors instead of traditional analog detectors, resulting in a step change in performance that approximately doubles sensitivity gain, volumetric resolution and quantitative accuracy compared to analog systems. These radical improvements can ultimately be translated into high image quality, increased diagnostic confidence, improved treatment planning and faster workflows.

 
“Personalized medicine will require a patient-specific picture of the functional processes associated with disease,” said Pablo Ros, M.D. “Accurate quantification of processes is therefore an important requirement for functional imaging in diagnosis, therapy and research. The quantitative accuracy and remarkably clear images that the new digital PET/CT system delivers are a key step forward.”
 

In a recent survey, nine out of ten referring physicians preferred Vereos digital PET/CT images over images taken with an analog system. Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its digital PET/CT system in the United States.

 

Related Content

Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...